<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CONTEXT: Multiple <z:hpo ids='HP_0100568'>endocrine neoplasia</z:hpo> type 1 (MEN1) patients frequently develop <z:hpo ids='HP_0002044'>Zollinger-Ellison syndrome</z:hpo> (MEN1/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Although <z:e sem="disease" ids="C0017168,C0559234" disease_type="Disease or Syndrome;Finding" abbrv="">esophageal reflux</z:e> symptoms are common in these patients, little is known about long-term occurrence of severe peptic <z:e sem="disease" ids="C0014852" disease_type="Disease or Syndrome" abbrv="">esophageal disease</z:e> including strictures and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: The objective of the study was to prospectively analyze the frequency of severe peptic <z:e sem="disease" ids="C0014852" disease_type="Disease or Syndrome" abbrv="">esophageal disease</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e> patients with and without MEN1 </plain></SENT>
<SENT sid="3" pm="."><plain>SETTING: The study was conducted at a tertiary care research center </plain></SENT>
<SENT sid="4" pm="."><plain>PATIENTS: Two hundred ninety-five patients (80 = MEN1/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e>, 215 = <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e>) participated in a prospective study </plain></SENT>
<SENT sid="5" pm="."><plain>INTERVENTIONS AND OUTCOME MEASURES: Assessment of MEN1, acid hypersecretion, upper gastrointestinal endoscopy/biopsies, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> status were measured initially and at each follow-up </plain></SENT>
<SENT sid="6" pm="."><plain>Esophageal manometry was performed in 89 patients </plain></SENT>
<SENT sid="7" pm="."><plain>Frequency and type of <z:e sem="disease" ids="C0014852" disease_type="Disease or Syndrome" abbrv="">esophageal disease</z:e> were correlated with clinical/laboratory/tumoral features of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e>/MEN1 </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: In MEN1/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e> patients, <z:hpo ids='HP_0002043'>esophageal stricture</z:hpo> was 3-fold higher, BE 5-fold higher, and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> 8-fold higher, and one patient died of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Esophageal symptoms were more frequent or severe in MEN1/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e>, but known risk factors for severe <z:e sem="disease" ids="C0014852" disease_type="Disease or Syndrome" abbrv="">esophageal disease</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e>-specific features did not differ between MEN1/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e> and <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>In MEN1/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e>, the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e> was 10 yr earlier, and H2-<z:chebi fb="68" ids="48706">antagonists</z:chebi> were used longer and at lower doses </plain></SENT>
<SENT sid="11" pm="."><plain>MEN1/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e> patients with <z:e sem="disease" ids="C0014852" disease_type="Disease or Syndrome" abbrv="">esophageal disease</z:e> differed from those without in that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e> diagnosis was delayed longer, esophageal symptoms were more frequent or severe, <z:hpo ids='HP_0002036'>hiatal hernias</z:hpo> were more frequent, <z:hpo ids='HP_0100633'>esophagitis</z:hpo> or pyloric <z:hpo ids='HP_0100699'>scarring</z:hpo> was more common, basal acid output was higher, and <z:hpo ids='HP_0000843'>hyperparathyroidism</z:hpo> was underdiagnosed </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: This study shows that MEN1/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ZES</z:e> patients have a higher incidence of severe <z:e sem="disease" ids="C0014852" disease_type="Disease or Syndrome" abbrv="">esophageal disease</z:e> including the <z:e sem="disease" ids="C0032927" disease_type="Neoplastic Process" abbrv="">premalignant condition</z:e> BE and identifies factors important for their pathogenesis that need to be incorporated into their long-term treatment </plain></SENT>
</text></document>